Home > Compound List > Product Information
Tetrabutylammonium fluoride solution_Molecular_structure_CAS_429-41-4)
Click picture or here to close

Tetrabutylammonium fluoride solution

Catalog No. 86923 Name Sigma Aldrich
CAS Number 429-41-4 Website http://www.sigmaaldrich.com
M. F. C16H36FN Telephone 1-800-521-8956
M. W. 261.4621432 Fax
Purity Email
Storage Chembase ID: 94540

SYNONYMS

Title
四丁基氟化铵 溶液
IUPAC name
tetrabutylazanium fluoride
IUPAC Traditional name
tetrabutylammonium fluoride
Synonyms
TBAF solution
TBAF 溶液

DATABASE IDS

MDL Number MFCD00011747
Beilstein Number 3762762
CAS Number 429-41-4

PROPERTIES

Concentration ~75% in H2O (NT)
Grade purum
Linear Formula [CH3(CH2)3]4NF
Refractive Index n20/D 1.456
GHS Pictograms GHS05
GHS Signal Word Danger
GHS Hazard statements H314
European Hazard Symbols Corrosive Corrosive (C)
MSDS Link Download
Personal Protective Equipment Faceshields, full-face respirator (US), Gloves, Goggles, multi-purpose combination respirator cartridge (US), type ABEK (EN14387) respirator filter
GHS Precautionary statements P280-P305 + P351 + P338-P310
RID/ADR UN 1760 8/PG 2
Risk Statements 34
Safety Statements 26-36/37/39-45
Hazard Class 8
UN Number 1760
Packing Group 2
German water hazard class 3

DETAILS

Description (English)
Application
Reactant for preparation of:
• Triple monoamine reuptake inhibitors as a new generation of antidepressants1
• Alcohols via hydrolysis of alkyl silyl ethers neutral pH in mixed organic-aqueous buffered solutions2
• Oligoribonucleotides with phosphonate-modified linkages3
• Aryl alkyl alcohols via Nozaki-Hiyama allylation catalyzed by chiral bipyridyldiol ligands and chromium trichloride4
• Conjugated dienoic acid esters using Suzuki coupling reactions5
• Macrocyclic o-aminobenzamide Hsp90 inhibitorwith antitumor activity6
• Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors7
• Anti-diabetic polyacetylenic glucosides8
Description (简体中文)
Application
Reactant for preparation of:
• Triple monoamine reuptake inhibitors as a new generation of antidepressants1
• Alcohols via hydrolysis of alkyl silyl ethers neutral pH in mixed organic-aqueous buffered solutions2
• Oligoribonucleotides with phosphonate-modified linkages3
• Aryl alkyl alcohols via Nozaki-Hiyama allylation catalyzed by chiral bipyridyldiol ligands and chromium trichloride4
• Conjugated dienoic acid esters using Suzuki coupling reactions5
• Macrocyclic o-aminobenzamide Hsp90 inhibitorwith antitumor activity6
• Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors7
• Anti-diabetic polyacetylenic glucosides8

REFERENCES